Status:
COMPLETED
Combined Simultaneous EGD-colonoscopy Trial (CoSi Endoscopy)
Lead Sponsor:
EmuraCenter LatinoAmerica
Collaborating Sponsors:
Universidad de la Sabana
Conditions:
Procedure Time
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The COVID -19 pandemic has reduced endoscopy services to an average of 83% producing a significant economic impact on endoscopy units worldwide. Endoscopy as an aerosol-generating procedure requires e...
Detailed Description
Study type: This is a prospective controlled randomized study to determine differences in procedure times of simultaneous EGD-colonoscopy and serial EGD-colonoscopy. Patients are randomized into two ...
Eligibility Criteria
Inclusion
- Eligible patients are those scheduled for EGD and colonoscopy at EmuraCenter Latinoamerica, Bogota DC, Colombia between June and August 2020. Procedure indications: abdominal pain, chronic anemia, chronic diarrhea, cancer screening, gastrointestinal bleeding.
Exclusion
- Exclusion criteria are inadequate bowel preparation with Boston score with at least 1 point in any segment, residual gastric food, previous surgery of the digestive tract, and refusal to participate.
Key Trial Info
Start Date :
June 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 23 2020
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04473456
Start Date
June 13 2020
End Date
September 23 2020
Last Update
December 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
EmuraCenter LatinoAmerica
Bogota, Cundinamarca, Colombia, 110121